/R E P E A T — Khiron Enters Exclusive Partnership with RAPPI, Latin America’s premier Residence Multi-Vertical App Platform/

/R E P E A T — Khiron Enters Exclusive Partnership with RAPPI, Latin America’s premier Residence Multi-Vertical App Platform/

News supplied by

Share this informative article

  • Rappi may be the biggest house multi-Vertical application in Latin America , which received a USD 1 Billion investment from Softbank Group Corp. and Softbank Vision Fund, reaching unicorn status in 2019. Rappi runs in Brazil , Colombia , Mexico , Argentina , Chile , Costa Rica , Uruguay , Ecuador and Peru , which together represent a population of over 600 million individuals.
  • Rappi’s multi-vertical application provides electronic banking and re re payment solutions, along with sets from meals to pharmaceutical items, customer package items and courier solutions, with on average significantly more than 10 million active users month-to-month, in accordance with research company Apptopia.
  • Expansive contract begins by having a 6-month exclusive circulation between Rappi and Khiron to introduce and distribute the business’s CPG item portfolio across Latin America through the Rappi platform.
  • Utilizing the possibility of future expansion, the partnership permits Khiron to introduce its CBD products in most nation where Rappi has a recognised existence, leveraging a quickly growing trend toward online product sales and last-mile distribution. The contract is anticipated to lessen general item launch and, logistics expenses, increasing access and contact with an incredible number of customers, and enhancing margins for both events.
  • The Kuida TM store that is in-app Rappi was released in Colombia in May 2020 . The businesses plan to expand circulation through RappiВґs consumer that is fast growing to Uruguay and Costa Rica , where Kuida is authorized, along with other nations such as for instance Brazil , Mexico and Chile , susceptible to regulatory approvals.

TORONTO , Sept. 3, 2020 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or perhaps the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically incorporated cannabis frontrunner with core operations in Latin America and Europe , announced today so it has entered into a distribution that is exclusive with Rappi SAS, the best Latin American last-mile multi-vertical platform that is supported having a USD 1 billion investment from Softbank Group Corp., and Softbank Vision Fund. The agreement that is expansive a 6-month exclusive distribution partnership between Rappi and Khiron to introduce and circulate the business’s CPG item portfolio across Latin America through the Rappi platform, you start with Kuida TM , the business’s branded CBD skincare products, because of the prospective to construct from the partnership in the long run.

This expanded partnership introduces the Company’s CBD-based Wellbeing products to millions of Rappi users across Latin America through its sophisticated technology and advanced, customer-centric marketing strategies beyond a standard vendor agreement. Using the Kuida store currently launched on Rappi in might 2020 when it comes to market that is colombian circulation is expanded to Uruguay and Costa Rica , where Kuida happens to be recently authorized. The organization also promises to introduce its products through Rappi’s fast consumer that is growing to nations such as for example Brazil , Mexico , Ecuador and Chile , at the mercy of regulatory approvals.

Colombia’s Rappi may be the market leading application that is multi-vertical Latin America with an existence in Brazil , Colombia , Mexico , Argentina , Chile , Ecuador , Costa Rica , Uruguay and Peru . Through its platform, clients purchase items and solutions and enjoy house distribution across multiple groups, including, medical, wellness, grocery, restaurants, pharmacies, drink and professional services amongst others. In addition, the applying features a digital wallet, RappiPay TM , where users could make P2P transfers and payments. Rappi has on average a lot more than 10 million users that are active, in accordance with research company Apptopia, supplying deliveries for nearly 100,000 organizations in LatAm, including over 13 million deliveries in Colombia alone.

“Rappi could be the distribution brand name that everybody in Latin America understands and utilizes daily. The partnership with Rappi decreases our item launch and logistics expenses and transforms our supply and visibility to an incredible number of clients throughout the area. Rappi could be the last-mile distribution brand name that may help us bring Khiron item to more clients than in the past. We have been proud to determine this partnership that is first-of-its-kind both of these companies, that are both industry leaders in LatAm, and had been both created by Colombians,” comments Alvaro Torres , Khiron CEO and manager.

“Once the marketplace for customer cannabis products globalizes it really is a normal complement us to partner with Khiron to meet up with our software usersВґ requires. They are a recognized leader in the region, and an innovator in bringing quality products to market, “comments Simon Borrero , Rappi SAS CEO like us.

About Khiron Lifetime Sciences Corp.

Khiron Life Sciences Corp. could be the principal built-in medical cannabis business in Latin America . Khiron has core operations in Latin America , along side task in the united states and European countries , and it is certified in Colombia when it comes to cultivation, manufacturing, domestic circulation, and worldwide export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. The organization delivers well in course regulatory conformity, is completely authorized to produce and fill prescriptions for high- and low-THC medical cannabis in Colombia and contains the initial approved type of CBD aesthetic items on rack in Colombia, and obtainable in the usa together with great britain .

The company combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people with a focused regional strategy and patient oriented approach. The business is led by Co-founder and Chief Executive Officer, Alvaro Torres , as well as a skilled professional team, and a qualified Board of Directors that features former President of Mexico , Vicente Fox .

Cautionary Notes

Forward-Looking Statements

This news release may include specific information that is”forward-looking and “forward-looking statements” in the meaning of relevant securities legislation. All information contained herein that isn’t historic in general may constitute information that is forward-looking. Khiron undertakes no responsibility to comment analyses, objectives or statements created by third-parties in respect of Khiron, its securities, or monetary or working outcomes (as relevant). Although Khiron believes that the objectives reflected in forward-looking statements in this news release are reasonable, such forward-looking declaration has been according to objectives, facets and presumptions concerning future activities which might turn out to be inaccurate and are also susceptible to many dangers and uncertainties, particular of that are beyond Khiron’s control, like the danger factors discussed in Khiron’s yearly Information Form that is available on Khiron’s SEDAR profile at sedar . The information that is forward-looking in this pr release is expressly qualified by this cautionary declaration and generally are made at the time of the date hereof. Khiron disclaims any intention and has now no responsibility or obligation, except as required for legal reasons, to upgrade or revise any information that is forward-looking whether as a consequence of brand brand new information, future occasions or perhaps.

Neither the TSXV nor its Regulation Services Provider (as that term is defined into the policies regarding the TSXV) takes duty when it comes to accuracy or adequacy of the pr release.